These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
358 related items for PubMed ID: 28666611
1. Treatment of xanthelasma palpebrarum with a 1064-nm, Q-switched Nd:YAG laser. Heng JK, Chua SH, Goh CL, Cheng S, Tan V, Tan WP. J Am Acad Dermatol; 2017 Oct; 77(4):728-734. PubMed ID: 28666611 [Abstract] [Full Text] [Related]
2. Is Q-switched neodymium-doped yttrium aluminium garnet laser an effective approach to treat xanthelasma palpebrarum? Results from a clinical study of 76 cases. Karsai S, Schmitt L, Raulin C. Dermatol Surg; 2009 Dec; 35(12):1962-9. PubMed ID: 19708874 [Abstract] [Full Text] [Related]
3. Treatment of xanthelasma palpebrarum by 1064-nm Q-switched Nd:YAG laser: a study of 11 cases. Fusade T. Br J Dermatol; 2008 Jan; 158(1):84-7. PubMed ID: 17916214 [Abstract] [Full Text] [Related]
4. About the treatment of xanthelasma palpebrarum using a 1,064 Q-switched neodymium-doped yttrium aluminum garnet laser. Fusade T. Dermatol Surg; 2011 Mar; 37(3):403-4. PubMed ID: 21410824 [No Abstract] [Full Text] [Related]
5. Erbium:yttrium aluminum garnet laser versus Q-switched neodymium:yttrium aluminum garnet laser for the treatment of xanthelasma palpebrarum. Balevi A, Ustuner P, Ozdemir M. J Cosmet Laser Ther; 2017 Apr; 19(2):100-105. PubMed ID: 27849400 [Abstract] [Full Text] [Related]
6. 1064-nm Q-switched Nd:YAG laser is an effective and safe approach to treat xanthelasma palpebrarum in Asian population. Zhao Y, Wen CM, Zhou NN, Feng Q, Tu P. J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2263-5. PubMed ID: 24909746 [No Abstract] [Full Text] [Related]
7. Combination of CO2 and Q-switched Nd:YAG lasers is more effective than Q-switched Nd:YAG laser alone for eyebrow tattoo removal. Radmanesh M, Rafiei Z. J Cosmet Laser Ther; 2015 Apr; 17(2):65-8. PubMed ID: 25411720 [Abstract] [Full Text] [Related]
8. A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminium garnet laser for the treatment of café-au-lait macules. Kim HR, Ha JM, Park MS, Lee Y, Seo YJ, Kim CD, Lee JH, Im M. J Am Acad Dermatol; 2015 Sep; 73(3):477-83. PubMed ID: 26169691 [Abstract] [Full Text] [Related]
9. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma. Fabi SG, Friedmann DP, Niwa Massaki AB, Goldman MP. Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301 [Abstract] [Full Text] [Related]
10. Systematic review of laser therapy in xanthelasma palpebrarum. Nguyen AH, Vaudreuil AM, Huerter CJ. Int J Dermatol; 2017 Mar; 56(3):e47-e55. PubMed ID: 28181222 [Abstract] [Full Text] [Related]
11. Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review. Levin MK, Ng E, Bae YS, Brauer JA, Geronemus RG. Lasers Surg Med; 2016 Feb; 48(2):181-7. PubMed ID: 26922302 [Abstract] [Full Text] [Related]
12. A split-face, evaluator-blind randomized study on the early effects of Q-switched Nd:YAG laser versus Er:YAG micropeel in light solar lentigines in Asians. Jun HJ, Kim SM, Choi WJ, Cho SH, Lee JD, Kim HS. J Cosmet Laser Ther; 2014 Apr; 16(2):83-8. PubMed ID: 24409833 [Abstract] [Full Text] [Related]
13. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective? Gokalp H, Akkaya AD, Oram Y. J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828 [Abstract] [Full Text] [Related]
14. Clinical efficacy of 1,444nm Nd:YAG laser for xanthelasma palpebrarum. Park JH, Ryu SI, Kim IH. J Cosmet Laser Ther; 2020 Apr 02; 22(3):141-145. PubMed ID: 32436411 [Abstract] [Full Text] [Related]
15. Q-switched Nd:YAG laser treatment for labial lentigines associated with Peutz-Jeghers syndrome. Ge Y, Jia G, Lin T. J Dtsch Dermatol Ges; 2015 Jun 02; 13(6):551-5. PubMed ID: 26018367 [Abstract] [Full Text] [Related]
16. Fractional, nonablative Q-switched 1,064-nm neodymium YAG laser to rejuvenate photoaged skin: a pilot case series. Luebberding S, Alexiades-Armenakas MR. J Drugs Dermatol; 2012 Nov 02; 11(11):1300-4. PubMed ID: 23135078 [Abstract] [Full Text] [Related]
17. Low-fluence Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser for the treatment of facial partial unilateral lentiginosis in Koreans. Lee Y, Choi EH, Lee SW. Dermatol Surg; 2012 Jan 02; 38(1):31-7. PubMed ID: 22093176 [Abstract] [Full Text] [Related]
18. Long-wave plasma radiofrequency ablation for treatment of xanthelasma palpebrarum. Baroni A. J Cosmet Dermatol; 2019 Feb 02; 18(1):121-123. PubMed ID: 29493071 [Abstract] [Full Text] [Related]
19. High-fluence 1064-nm Q-Switched Nd:YAG laser: Safe and effective treatment of café-au-lait macules in Asian patients. Baek JO, Park IJ, Lee KR, Ryu HR, Kim J, Lee S, Kim YR, Hur H. J Cosmet Dermatol; 2018 Jun 02; 17(3):380-384. PubMed ID: 29726114 [Abstract] [Full Text] [Related]
20. Treatment of acquired bilateral nevus of ota-like macules (Hori's nevus) with a combination of the 532 nm Q-Switched Nd:YAG laser followed by the 1,064 nm Q-switched Nd:YAG is more effective: prospective study. Ee HL, Goh CL, Khoo LS, Chan ES, Ang P. Dermatol Surg; 2006 Jan 02; 32(1):34-40. PubMed ID: 16393596 [Abstract] [Full Text] [Related] Page: [Next] [New Search]